Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

PURPOSE: Response evaluation in patients with glioblastoma after chemoradiotherapy is challenging due to progressive, contrast-enhancing lesions on MRI that do not reflect true tumour progression. In this study, we prospectively evaluated the ability of the PET tracer (18)F-fluorothymidine (FLT), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brahm, Cyrillo G., den Hollander, Martha W., Enting, Roelien H., de Groot, Jan Cees, Solouki, A. Millad, den Dunnen, Wilfred F. A., Heesters, Mart A. A. M., Wagemakers, Michiel, Verheul, Henk M. W., de Vries, Elisabeth G. E., Pruim, Jan, Walenkamp, Annemiek M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208814/
https://www.ncbi.nlm.nih.gov/pubmed/30032322
http://dx.doi.org/10.1007/s00259-018-4090-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208814/
https://www.ncbi.nlm.nih.gov/pubmed/30032322
http://dx.doi.org/10.1007/s00259-018-4090-4

Ejemplares similares